BioHealth News
TEDCO’s Pre-Seed Rural Business Innovation Initiative Invests in NEOPATHOLOGY CORP.
Rural Maryland-based biotechnology business seeks to develop new methods for image-based tissue diagnostics and assays COLUMBIA, Md., (August 27, 2024) — TEDCO, Maryland’s economic…
Read More
Johns Hopkins Technology Ventures Celebrates a Decade of Innovation with the Release of FY24 Annual Report
Johns Hopkins Technology Ventures (JHTV) has proudly released its FY24 Annual Report, marking ten years of exceptional growth in innovation and entrepreneurship. The report…
Read More
September 9th: HJF Networking and Educational Series
HJF, Montgomery County, Maryland & BioBuzz We are teaming up to bring the research community a new and exciting opportunity - the HJF Networking…
Read More
TEDCO Invests in Simmbion, LLC
COLUMBIA, Md., (August 26, 2024) — TEDCO, Maryland’s economic engine for technology companies, announced a recent $200,000 Pre-Seed Builder Fund investment in Simmbion, LLC.…
Read More
Techstars, Johns Hopkins University, and CareFirst BlueCross BlueShield to Bring Healthcare AI Accelerator to Baltimore
BALTIMORE--(BUSINESS WIRE)--Techstars, Johns Hopkins University, and CareFirst BlueCross BlueShield (CareFirst) announced today a collaboration to launch a new healthcare accelerator program designed to support early-stage entrepreneurs building…
Read More
NIH SBIR Cycle is Opening: Deadline Approaching on January 5th, 2025
The next cycle of the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program is just around the corner, with a critical…
Read More
Meet the BHI Analyst Team at the BioHealth Capital Region Investment Conference
This September 19th, the BioHealth Capital Region Investment Conference will once again serve as a premier gathering for the biopharma sector, uniting a dynamic…
Read More
Navigating Workforce Trends in Biotech and Government: Insights with Brad Sibbald and Sarah Porter of Kelly Services
In this episode of BioTalk, Rich Bendis, President and CEO of BioHealth Innovation, Inc., welcomes Brad Sibbald, Vice President of Kelly Science and Clinical,…
Read More
Key Insights from Wilson Sonsini’s Entrepreneurs Report: 1H 2024
Wilson Sonsini's Entrepreneurs Report for the first half of 2024 is now available, offering critical insights into the current private company financing landscape. Valuations…
Read More
Hopkins Team Awarded Up To $20.9 Million in ARPA-H Funding to Further Tumor-Removal Research
A Whiting School-led interinstitutional research team will develop a novel photoacoustic endoscope and fluorescent contrast agent to ensure total tumor removal and preservation of…
Read More
WBJ: Virginia Tech taps D.C. incubator leader Sally Allain for new role
By Sara Gilgore – Staff Reporter, Washington Business Journal Aug 21, 2024 - Sally Allain, the inaugural head of Johnson & Johnson Innovation’s D.C.…
Read More
Falls Church’s Retension Pharmaceuticals Closes $10.4 Million Oversubscribed Series A to Fund Clinical Trials for Patients Suffering from Resistant and Uncontrolled Hypertension
FALLS CHURCH, Va.--(BUSINESS WIRE)--Retension Pharmaceuticals, Inc. is pleased to announce the successful closing of its Series A $10.4 million financing round to initiate a well-powered…
Read More
Explore the World of Technology Transfer and Commercialization with the Technology Transfer Society – Washington D.C. Chapter
The Technology Transfer Society – Washington D.C. Chapter is excited to announce its Fall 2024 course, "Introduction to Technology Transfer and Commercialization," offered in…
Read More
UVA Engineering Professor’s $600,000 Grant Set to Innovate Pediatric Brain Tumor Treatment
Natasha Sheybani, assistant professor of biomedical engineering at the University of Virginia School of Engineering, will collaborate with researchers at Children’s National Hospital to…
Read More
OS Therapies Accepted Into Johnson & Johnson Innovation – JLABS
ROCKVILLE, Md.--(BUSINESS WIRE)--OS Therapies (NYSE American: OSTX) (“OS Therapies” or “the Company”), an ADC and Immunotherapy research and clinical-stage biopharmaceutical company, today announced that it…
Read More